Yehuda Eliya insider trades
Open-market stock purchases and sales by Yehuda Eliya, Director at Raphael Pharmaceutical Inc, from SEC Form 4 filings since May 12, 2022.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- RAPH Raphael Pharmaceutical Inc: other filings, last Mar 10, 2025